Difference between revisions of "Pitt JM, et al. J. Clin. Invest. (2016) cited as Ref 546 in DOI: 10.1038/s41392-020-0110-5 (Q9809)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): J. Clin. Invest., #quickstatements; #temporary_batch_1590006349955) |
(Created claim: Page(s) (P105): 1224-, #quickstatements; #temporary_batch_1590074839150) |
||
(2 intermediate revisions by the same user not shown) | |||
Property / Volume | |||
+ | 126 | ||
Property / Volume: 126 / rank | |||
+ | Normal rank | ||
Property / title | |||
+ | Dendritic cell-derived exosomes for cancer therapy (English) | ||
Property / title: Dendritic cell-derived exosomes for cancer therapy (English) / rank | |||
+ | Normal rank | ||
Property / Page(s) | |||
+ | 1224- | ||
Property / Page(s): 1224- / rank | |||
+ | Normal rank |
Latest revision as of 15:44, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Pitt JM, et al. J. Clin. Invest. (2016) cited as Ref 546 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Pitt JM
0 references
2016
0 references
J. Clin. Invest.
0 references
126
0 references
Dendritic cell-derived exosomes for cancer therapy (English)
0 references
1224-
0 references